It will be interesting to investigate if inhibitors of this type are protective in cardiovascular and metabolic disease models and if they lack significant unwanted effects on other parameters, which Trpc5 knockout mouse studies have suggested might occur on joint inflammation37 and possibly on blood pressure38,39. This evidence concerns the gene TRPC5 and Other metabolic disease.